(Q33356900)

26 July 2017

1 reference

title

Controlling the resolution of acute inflammation: a new genus of dual anti-inflammatory and proresolving mediators (English)

1 reference

26 July 2017

0 references

0 references

1

Charles N Serhan

1 reference

26 July 2017

language of work or name

English

0 references

publication date

1 August 2008

1 reference

Journal of Periodontology

26 July 2017

published in

1 reference

26 July 2017

volume

79

1 reference

26 July 2017

issue

8 Suppl

1 reference

26 July 2017

page(s)

1520-1526

1 reference

Resolution phase of inflammation: novel endogenous anti-inflammatory and proresolving lipid mediators and pathways

26 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2008.080231

Anti-inflammatory actions of neuroprotectin D1/protectin D1 and its natural stereoisomers: assignments of dihydroxy-containing docosatrienes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2008.080231

Lipid mediator-induced expression of bactericidal/ permeability-increasing protein (BPI) in human mucosal epithelia

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2008.080231

Resolvin E1, an endogenous lipid mediator derived from omega-3 eicosapentaenoic acid, protects against 2,4,6-trinitrobenzene sulfonic acid-induced colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2008.080231

Resolvin E1 promotes mucosal surface clearance of neutrophils: a new paradigm for inflammatory resolution

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2008.080231

Lipoxin biosynthesis and its impact in inflammatory and vascular events

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2008.080231

The lipoxin receptor ALX: potent ligand-specific and stereoselective actions in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2008.080231

Aspirin triggers previously undescribed bioactive eicosanoids by human endothelial cell-leukocyte interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2008.080231

Lipoxins, aspirin-triggered epi-lipoxins, lipoxin stable analogues, and the resolution of inflammation: stimulation of macrophage phagocytosis of apoptotic neutrophils in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2008.080231

Lipoxins: endogenous regulators of inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2008.080231

Neutrophil-mediated changes in vascular permeability are inhibited by topical application of aspirin-triggered 15-epi-lipoxin A4 and novel lipoxin B4 stable analogues

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2008.080231

Design of lipoxin A4 stable analogs that block transmigration and adhesion of human neutrophils.

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2008.080231

Second-generation beta-oxidation resistant 3-oxa-lipoxin A4 analogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2008.080231

Design and synthesis of benzo-lipoxin A4 analogs with enhanced stability and potent anti-inflammatory properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2008.080231

Stereochemical assignment, antiinflammatory properties, and receptor for the omega-3 lipid mediator resolvin E1

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2008.080231

Novel docosatrienes and 17S-resolvins generated from docosahexaenoic acid in murine brain, human blood, and glial cells. Autacoids in anti-inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2008.080231

Novel functional sets of lipid-derived mediators with antiinflammatory actions generated from omega-3 fatty acids via cyclooxygenase 2-nonsteroidal antiinflammatory drugs and transcellular processing

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2008.080231

Resolvins: a family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammation signals

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2008.080231

Resolvin D1 and its aspirin-triggered 17R epimer. Stereochemical assignments, anti-inflammatory properties, and enzymatic inactivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2008.080231

Neuroprotectin D1: a docosahexaenoic acid-derived docosatriene protects human retinal pigment epithelial cells from oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2008.080231

Novel docosanoids inhibit brain ischemia-reperfusion-mediated leukocyte infiltration and pro-inflammatory gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2008.080231

A role for the mouse 12/15-lipoxygenase pathway in promoting epithelial wound healing and host defense

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2008.080231

Molecular circuits of resolution: formation and actions of resolvins and protectins

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2008.080231

Lipid mediator class switching during acute inflammation: signals in resolution.

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2008.080231

Resolution of inflammation: the beginning programs the end

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2008.080231

Lipoxin A4 and B4 are potent stimuli for human monocyte migration and adhesion: selective inactivation by dehydrogenation and reduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2008.080231

Chemistry and metabolism of lipids in the vertebrate retina

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2008.080231

The role of omega-3 long-chain polyunsaturated fatty acids in health and disease of the retina

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2008.080231

Increased dietary intake of omega-3-polyunsaturated fatty acids reduces pathological retinal angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2008.080231

Lipoxins and novel 15-epi-lipoxin analogs display potent anti-inflammatory actions after oral administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2008.080231

Prospects for research in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2008.080231

A beta-oxidation-resistant lipoxin A4 analog treats hapten-induced colitis by attenuating inflammation and immune dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2008.080231

Resolvin E1 and protectin D1 activate inflammation-resolution programmes

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2008.080231

Fat-1 mice convert n-6 to n-3 fatty acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2008.080231

21 January 2018

Identifiers

DOI

10.1902/JOP.2008.080231

1 reference

26 July 2017

1 reference